News
Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...
Regents of the Univ. of California v. Broad Inst., Inc., No. 2022-1594, 2025 WL 1363125 (Fed. Cir. May 12, 2025) - On May 12, ...
21h
AZoLifeSciences on MSNEpigenome Editing: Enhancing Endonuclease Protein Design for In Vivo ApplicationsResearchers have engineered a compact, high-specificity IscB variant, NovaIscB, for safe, persistent in vivo epigenome ...
17h
New Scientist on MSNWe’re getting close to recreating the first step in evolution of lifeLife is thought to have begun when RNA began replicating itself, and researchers have got close to achieving this in the lab ...
Parkinson's disease is best known for its effects on the central nervous system. In addition, recent scientific advances ...
Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, ...
The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.
Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results